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Background
Gadolinium based contrast agents are frequently given
to patients who undergo a Cardiac MRI examination to
maximize contrast between normal and abnormal tis-
sues in order to demonstrate pathologies such as scar or
fibrosis in the heart and for MR angiography. Multi-
hance® (gadobenate dimeglumine, Bracco Diagnostics)
is a common selection because of its properties of high
T1 relaxivity. While contrast reactions are rare we have
anecdotally observed that patients of certain racial back-
grounds appear more likely to experience reactions of
nausea or vomiting after Multihance® infusion and
sought to formally examine this possible relationship.
Methods
We retrospectively identified 1773 consecutive CMR
examinations over a 4 year period (2010-2014) utilizing
Multihance® from our CMR clinical database. These
included 161 (9.1%: 58% male, 42% female) patients of
self-described African descent. The remaining 1612 indi-
viduals were of other races, predominately Caucasian
(68.6%: 63% male, 47% female) with a small minority of
Asian (3.4%: 58% male, 32% female), Hispanic (4.9%:
64% male, 46% female) and other (0.5%: 25% male, 75%
female) populations. An additional 240 individuals
elected not to report ethnicity (13.5%: 75% male, 25%
female) Patients were told that no preparation was
required for their examination; therefore the time since
their last meal was unknown. All individuals were moni-
tored in the same way during their study including ECG,
non-invasive blood pressure and respiratory monitoring.
Verbal communication was maintained with all indivi-
duals before, during and after the administration of the
contrast agent.
Results
There were a total of 31 (1.75%: 77% male, 23% female)
reactions involving nausea and vomiting immediately
after Multihance® infusion including 12 (7.5%: 83%
male, 17% female) African descent, 17 (1.4%: 71% male,
29% female; p<0.0001 vs. non-African descent) Cauca-
sian, 1 (1.5%: 100% male, 0% female) Hispanic and 1
(0.42%: 100% male, 0% female) of unknown race/ethni-
city (Figure 1).
Conclusions
In this consecutive, retrospective study of patients
referred for clinical CMR study, we found a much
higher incidence of nausea/vomiting reactions to the
Multihance® brand of gadolinium based contrast agent
in individuals of African descent as compared to indivi-
duals who identify themselves as of non-African descent.
Further prospective studies are needed to determine if
this finding remains consistent and if ethnicity should
be considered in the choice of CMR contrast agent.
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